SEC Form 4 · accession 0001123292-15-001361
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis T Williams
Officer — President and CEO · Director
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 16, 2015 | A | 50,000 | $0.00 | A | 341,256 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock, which will vest according to the following schedule: 50% of the restricted stock vests on September 1, 2016 with the remainder vesting on March 1, 2017, provided the reporting person continues to be employed by the Company or serve as a member of the Board of Directors of the Company through each such date.